Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Cash from Investing Activities (2020 - 2025)

Maxcyte (MXCT) has disclosed Cash from Investing Activities for 6 consecutive years, with $5.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 43.9% to $5.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $14.6 million, a 227.37% increase, with the full-year FY2024 number at $6.9 million, down 87.39% from a year prior.
  • Cash from Investing Activities was $5.2 million for Q3 2025 at Maxcyte, up from $1.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $194.8 million in Q1 2022 to a low of -$162.3 million in Q3 2021.
  • A 5-year average of -$7.5 million and a median of $1.5 million in 2025 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: crashed 2939.61% in 2021, then surged 1141.41% in 2022.
  • Maxcyte's Cash from Investing Activities stood at -$11.4 million in 2021, then tumbled by 136.88% to -$27.1 million in 2022, then soared by 84.72% to -$4.1 million in 2023, then surged by 59.77% to -$1.7 million in 2024, then soared by 411.83% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Cash from Investing Activities are $5.2 million (Q3 2025), $1.5 million (Q2 2025), and $9.5 million (Q1 2025).